1832 related articles for article (PubMed ID: 11257121)
21. Social stress is lethal in the mdx model of Duchenne muscular dystrophy.
Razzoli M; Lindsay A; Law ML; Chamberlain CM; Southern WM; Berg M; Osborn J; Engeland WC; Metzger JM; Ervasti JM; Bartolomucci A
EBioMedicine; 2020 May; 55():102700. PubMed ID: 32192914
[TBL] [Abstract][Full Text] [Related]
22. Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.
van der Pijl EM; van Putten M; Niks EH; Verschuuren JJ; Aartsma-Rus A; Plomp JJ
Eur J Neurosci; 2016 Jun; 43(12):1623-35. PubMed ID: 27037492
[TBL] [Abstract][Full Text] [Related]
23. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T
Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842
[TBL] [Abstract][Full Text] [Related]
24. Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy.
Rooney JE; Gurpur PB; Burkin DJ
Proc Natl Acad Sci U S A; 2009 May; 106(19):7991-6. PubMed ID: 19416897
[TBL] [Abstract][Full Text] [Related]
25. Three mouse models of muscular dystrophy: the natural history of strength and fatigue in dystrophin-, dystrophin/utrophin-, and laminin alpha2-deficient mice.
Connolly AM; Keeling RM; Mehta S; Pestronk A; Sanes JR
Neuromuscul Disord; 2001 Nov; 11(8):703-12. PubMed ID: 11595512
[TBL] [Abstract][Full Text] [Related]
26. Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy.
Deconinck AE; Rafael JA; Skinner JA; Brown SC; Potter AC; Metzinger L; Watt DJ; Dickson JG; Tinsley JM; Davies KE
Cell; 1997 Aug; 90(4):717-27. PubMed ID: 9288751
[TBL] [Abstract][Full Text] [Related]
27. Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice.
Li D; Long C; Yue Y; Duan D
Hum Mol Genet; 2009 Apr; 18(7):1209-20. PubMed ID: 19131360
[TBL] [Abstract][Full Text] [Related]
28. Sarcospan reduces dystrophic pathology: stabilization of the utrophin-glycoprotein complex.
Peter AK; Marshall JL; Crosbie RH
J Cell Biol; 2008 Nov; 183(3):419-27. PubMed ID: 18981229
[TBL] [Abstract][Full Text] [Related]
29. Independent variability of microtubule perturbations associated with dystrophinopathy.
Belanto JJ; Olthoff JT; Mader TL; Chamberlain CM; Nelson DM; McCourt PM; Talsness DM; Gundersen GG; Lowe DA; Ervasti JM
Hum Mol Genet; 2016 Nov; 25(22):4951-4961. PubMed ID: 28171583
[TBL] [Abstract][Full Text] [Related]
30. Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype.
Galbiati F; Volonte D; Chu JB; Li M; Fine SW; Fu M; Bermudez J; Pedemonte M; Weidenheim KM; Pestell RG; Minetti C; Lisanti MP
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9689-94. PubMed ID: 10931944
[TBL] [Abstract][Full Text] [Related]
31. Alpha7beta1 integrin does not alleviate disease in a mouse model of limb girdle muscular dystrophy type 2F.
Milner DJ; Kaufman SJ
Am J Pathol; 2007 Feb; 170(2):609-19. PubMed ID: 17255329
[TBL] [Abstract][Full Text] [Related]
32. Human α7 Integrin Gene (ITGA7) Delivered by Adeno-Associated Virus Extends Survival of Severely Affected Dystrophin/Utrophin-Deficient Mice.
Heller KN; Montgomery CL; Shontz KM; Clark KR; Mendell JR; Rodino-Klapac LR
Hum Gene Ther; 2015 Oct; 26(10):647-56. PubMed ID: 26076707
[TBL] [Abstract][Full Text] [Related]
33. Dystrophin and utrophin: genetic analyses of their role in skeletal muscle.
Rafael JA; Brown SC
Microsc Res Tech; 2000 Feb 1-15; 48(3-4):155-66. PubMed ID: 10679963
[TBL] [Abstract][Full Text] [Related]
34. Talin, vinculin and DRP (utrophin) concentrations are increased at mdx myotendinous junctions following onset of necrosis.
Law DJ; Allen DL; Tidball JG
J Cell Sci; 1994 Jun; 107 ( Pt 6)():1477-83. PubMed ID: 7962191
[TBL] [Abstract][Full Text] [Related]
35. Compensation for dystrophin-deficiency: ADAM12 overexpression in skeletal muscle results in increased alpha 7 integrin, utrophin and associated glycoproteins.
Moghadaszadeh B; Albrechtsen R; Guo LT; Zaik M; Kawaguchi N; Borup RH; Kronqvist P; Schroder HD; Davies KE; Voit T; Nielsen FC; Engvall E; Wewer UM
Hum Mol Genet; 2003 Oct; 12(19):2467-79. PubMed ID: 12915458
[TBL] [Abstract][Full Text] [Related]
36. Stabilization of the cardiac sarcolemma by sarcospan rescues DMD-associated cardiomyopathy.
Parvatiyar MS; Brownstein AJ; Kanashiro-Takeuchi RM; Collado JR; Dieseldorff Jones KM; Gopal J; Hammond KG; Marshall JL; Ferrel A; Beedle AM; Chamberlain JS; Renato Pinto J; Crosbie RH
JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31039133
[TBL] [Abstract][Full Text] [Related]
37. Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy.
Ahmad A; Brinson M; Hodges BL; Chamberlain JS; Amalfitano A
Hum Mol Genet; 2000 Oct; 9(17):2507-15. PubMed ID: 11030755
[TBL] [Abstract][Full Text] [Related]
38. Nitric oxide and l-arginine cause an accumulation of utrophin at the sarcolemma: a possible compensation for dystrophin loss in Duchenne muscular dystrophy.
Chaubourt E; Fossier P; Baux G; Leprince C; Israël M; De La Porte S
Neurobiol Dis; 1999 Dec; 6(6):499-507. PubMed ID: 10600405
[TBL] [Abstract][Full Text] [Related]
39. Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses.
Côté PD; Moukhles H; Lindenbaum M; Carbonetto S
Nat Genet; 1999 Nov; 23(3):338-42. PubMed ID: 10610181
[TBL] [Abstract][Full Text] [Related]
40. Constitutive properties, not molecular adaptations, mediate extraocular muscle sparing in dystrophic mdx mice.
Porter JD; Merriam AP; Khanna S; Andrade FH; Richmonds CR; Leahy P; Cheng G; Karathanasis P; Zhou X; Kusner LL; Adams ME; Willem M; Mayer U; Kaminski HJ
FASEB J; 2003 May; 17(8):893-5. PubMed ID: 12670877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
